Cargando…
Sodium-glucose cotransporter-2-induced euglycemic diabetic ketoacidosis unmasks latent autoimmune diabetes in a patient misdiagnosed with type 2 diabetes mellitus: a case report
BACKGROUND: Euglycemic diabetic ketoacidosis is an uncommon but life-threatening complication associated with the use of sodium-glucose cotransporter 2 inhibitors that causes lower than expected blood glucose levels typically seen in diabetic ketoacidosis. CASE PRESENTATION: We present a case of 64-...
Autores principales: | Vadasz, Brian, Arazi, Mattan, Shukha, Yousef, Koren, Ofir, Taher, Riad |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7882073/ https://www.ncbi.nlm.nih.gov/pubmed/33581735 http://dx.doi.org/10.1186/s13256-020-02607-2 |
Ejemplares similares
-
Euglycemic Diabetic Ketoacidosis With Prolonged Glucosuria Associated With the Sodium-Glucose Cotransporter-2 Canagliflozin
por: Kelmenson, Daniel A., et al.
Publicado: (2017) -
Euglycemic Diabetic Ketoacidosis: A Potential Complication of Treatment With Sodium–Glucose Cotransporter 2 Inhibition
por: Peters, Anne L., et al.
Publicado: (2015) -
Sodium–Glucose Cotransporter 2 Inhibitors and Euglycemic Diabetic Ketoacidosis: Metabolic Acidosis With a Twist
por: Jaberi, Aala, et al.
Publicado: (2016) -
Diabetic Ketoacidosis in an Euglycemic Patient
por: Mumtaz, Hassan, et al.
Publicado: (2020) -
Euglycemic Diabetic Ketoacidosis in Pregnancy
por: de Alencar, Júlio César Garcia, et al.
Publicado: (2019)